R. Michael Carruthers
2012 - Array BioPharma
In 2012, R. Michael Carruthers earned a total compensation of $648.6K as Chief Financial Officer at Array BioPharma, a 19% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $63,368 |
|---|---|
| Option Awards | $154,260 |
| Salary | $341,250 |
| Stock Awards | $65,954 |
| Other | $23,750 |
| Total | $648,582 |
Carruthers received $341.3K in salary, accounting for 53% of the total pay in 2012.
Carruthers also received $63.4K in non-equity incentive plan, $154.3K in option awards, $66K in stock awards and $23.8K in other compensation.
Rankings
In 2012, R. Michael Carruthers' compensation ranked 7,844th out of 11,487 executives tracked by ExecPay. In other words, Carruthers earned more than 31.7% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,844 out of 11,487 | 32nd |
Division Manufacturing | 2,825 out of 4,253 | 34th |
Major group Chemicals And Allied Products | 741 out of 1,198 | 38th |
Industry group Drugs | 526 out of 920 | 43rd |
Industry Pharmaceutical Preparations | 415 out of 700 | 41st |
Source: SEC filing on September 13, 2013.
Carruthers' colleagues
We found three more compensation records of executives who worked with R. Michael Carruthers at Array BioPharma in 2012.